MANAGEMENT TEAM
James Bojdo, PhD
CEO & Co-Founder
James has more than 10 years of experience in preclinical research, with a major focus on animal model development, as well as pCRO and biotech experience. His vision is to create a company that improves the sector through better research models, and has brought together the right team to deliver this following extensive research. As well as spearheading the strategic growth of MediNect, James works with the whole team to ensure they have the tools to deliver the best service for our clients.
Kevin Harkin, PhD
Senior Study Director
Kevin conducted his PhD in the Xu/Chen lab out of Queen's University Belfast, specialising in Diabetic Retinopathy and retinal neurodegeneration, followed by several post-doc position in similar areas. Kevin's role in MediNect is predominantly client facing utilising his expertise to produce a robust study plan for our clients.
Prof. Alan Stitt,
PhD, MRIA, Gold FARVO
CSA & Co-Founder
Professor Stitt holds the distinguished position of Chair of Experimental Ophthalmology at Queen’s University Belfast and is renowned worldwide for his contributions to the field of ophthalmology. His primary research focus is on understanding the underlying mechanisms of retinal diseases, with a special emphasis on diabetic retinopathy and age-related macular degeneration (AMD). His outstanding research efforts have been recognized with numerous awards, including a Royal Society Merit Award, membership in the Royal Irish Academy (RIA), and a Fellowship with the Association for Research in Vision & Ophthalmology (ARVO).
He plays a vital role in the global academic community, offering his expertise on advisory boards and grant panels, and holding editorial positions within the field of ophthalmology. Alan's role in MediNect is to advise on study design and scientific and strategic guidance.
.jpg)
Ms. Lynsey-Dawn Allen
Principal In Vivo Scientist
LD has over 15 years of hands-on experience working out of the Stitt lab conducting in vivo techniques in over 100 different studies. LD leads the technical work for in vivo models. LD's role in MediNect is to conduct in vivo research and train in vivo scientists.
Tine Van Bergen, PhD
Scientific Advisor, Consultant
Tine has more than 15 years of experience in preclinical ophthalmology research, with a major focus on animal models for retinal diseases, ocular drug delivery, as well as pharmacological, pharmacokinetic and tolerability studies. She holds a master and doctoral degree in Biomedical Sciences from the University of Leuven, Belgium. She has around 10 years of experience in the biopharmaceutical industry, contributing to the preclinical drug development of various clinical-stage drug products for retinal eye diseases. Tine's role is on a consultancy basis and focuses on working with clients to create robust study plans and lead teams remotely, from Belgium.
Hanagh Winter, PhD
Business Development Manager
Another graduate from the Stitt Lab. Hanagh's research was focussed on the importance circadian rhythms impact on retinal function. With a passion for retina research Hanagh is now positioned to lead the business development team at MediNect and use her scientific background and her proven communication skills to ensure our clients are abreast of their study timelines.